BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8207718)

  • 1. The prevention and management of haemolytic disease of the newborn.
    Contreras M; de Silva M
    J R Soc Med; 1994 May; 87(5):256-8. PubMed ID: 8207718
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
    Contreras M
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
    [No Abstract]   [Full Text] [Related]  

  • 6. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Harding K
    Br J Obstet Gynaecol; 1997 Jul; 104(7):869-70. PubMed ID: 9236664
    [No Abstract]   [Full Text] [Related]  

  • 8. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 9. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 11. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
    Mikhaĭlova AA; Klimova NIa
    Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
    [No Abstract]   [Full Text] [Related]  

  • 12. The global burden of Rh disease.
    Zipursky A; Paul VK
    Arch Dis Child Fetal Neonatal Ed; 2011 Mar; 96(2):F84-5. PubMed ID: 21037283
    [No Abstract]   [Full Text] [Related]  

  • 13. Decline in deaths from rhesus haemolytic disease of the newborn.
    Clarke C; Hussey RM
    J R Coll Physicians Lond; 1994; 28(4):310-1. PubMed ID: 7965968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing struggle to eliminate hemolytic disease of the newborn from RH (D).
    Barlow JF
    S D J Med; 1999 Jan; 52(1):7-8. PubMed ID: 9926725
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 16. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversies in Rh prophylaxis.
    Hensleigh PA
    Am J Obstet Gynecol; 1985 Sep; 153(1):112-3. PubMed ID: 2994476
    [No Abstract]   [Full Text] [Related]  

  • 19. Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():iv, 1-44. PubMed ID: 10328662
    [No Abstract]   [Full Text] [Related]  

  • 20. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.